Carnegie acted as lead manager in the initial public offering of BioTie Therapies on the Helsinki Stock Exchange. BioTie Therapies is a leading Finnish biopharmaceutical company in its core business areas, focused to develop original biopharmaceutical and pharmaceutical products in the areas of inflammation, coagulation, thrombosis and cancer. BioTie Therapies is the first biopharmaceutical company ever listed on the Helsinki Stock Exchange. June, 2000.
Healthcare
Initial public offering of BioTie Therapies (FI) — EUR 21 million
June 2000